Rilonacept
IL1T-GA-0815
Phase 3 mab completed
Quick answer
Rilonacept for Gout is a Phase 3 program (mab) at REGENERON PHARMACEUTICALS, INC. with 3 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Gout
- Phase
- Phase 3
- Modality
- mab
- Status
- completed